Overcoming AAV Innate Immunity Barriers to Further Gene Therapy Development

Time: 11:30 am
day: Post-Conference Discussion Day - Track A


  • Current understanding of AAV innate immune response
  • Exploring the capsid and transgene immune response
  • How can we overcome innate immunity to AAV to ensure development of safer, more efficacious gene therapies?